跳至主要内容
临床试验/NCT03825809
NCT03825809招募中2 期

Traditional vs. Nonopioid Analgesia After Labral Surgery

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年1月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
100
试验地点
1
主要终点
Patient-Reported Outcomes Measurement Information System

研究概览

简要总结

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

详细描述

Study Design: This is a randomized, single blinded, standard of care-controlled clinical trial. All adult patients over eighteen desiring rotator cuff repair will be eligible. Nonnarcotic postoperative pain control regimen described below were chosen based on previous studies in fracture care and joint arthroplasty.

Patients will be consented and recruited. Once participation has been determined and consent obtained, the names of participating patients will be provided to the research pharmacy. Patients will be randomized with a computer-generated table in 2 patient blocks by the research pharmacy. Patients postoperative analgesia will be divided into one of the following 2 treatment arms: 1) A novel nonopioid pain protocol or 2) traditional narcotic pain analgesia

Primary endpoints is reduction in pain as measured by VAS and PROMIS. The endpoints will be collected at each post-operative day using a journal. Moreover, endpoints will be collected at the patient's first post-operative appointment. These appointments are scheduled within one-week of the index procedure.

Statistical Analysis

All continuous data will be analyzed using independent 2-group t tests and reported as means ± standard deviations. Categorical data will be compared between the 2 groups using chi-square tests and reported as counts and percentages. A preliminary test to confirm the quality of variances will be conducted prior to utilizing the t test to confirm the appropriate statistical analysis. Nonparametric equivalents Wilcoxon rank-sum and Fisher exact tests will be used as needed for nonnormal distributions and low variable numbers, respectively. A multivariable regression analysis was performed to assess for potential confounding demographic variables.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult patients over age 18 and scheduled for a primary or revision labral surgery

排除标准

  • Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff

研究组 & 干预措施

Post-Operative Non Opioid Pain Protocol

Experimental

Patients will be administered a post-operative non-opioid pain protocol consisting of:

Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam

干预措施: Celecoxib (Drug)

Post-Operative Non Opioid Pain Protocol

Experimental

Patients will be administered a post-operative non-opioid pain protocol consisting of:

Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam

干预措施: Ketorolac (Drug)

Post-Operative Non Opioid Pain Protocol

Experimental

Patients will be administered a post-operative non-opioid pain protocol consisting of:

Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam

干预措施: Gabapentin (Drug)

Post-Operative Non Opioid Pain Protocol

Experimental

Patients will be administered a post-operative non-opioid pain protocol consisting of:

Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam

干预措施: Acetaminophen (Drug)

Post-Operative Non Opioid Pain Protocol

Experimental

Patients will be administered a post-operative non-opioid pain protocol consisting of:

Celecoxib Ketorolac Gabapentin Acetaminophen Diazepam

干预措施: Diazepam (Drug)

Post-Operative Traditional Pain Protocol

Active Comparator

Patients will be administered a traditional post-operative pain protocol consisting of: Hydrocodone-acetaminophen 5-325

干预措施: Hydrocodone-Acetaminophen (Drug)

结局指标

主要结局

Patient-Reported Outcomes Measurement Information System

时间窗: 10 days post-operatively

Patient-Reported Outcomes Measurement Information System Physical Interference (PROMIS PI) nightly until study completion. Average PROMIS PI values calculated nightly. A higher score indicates more pain interference.

Pain Levels

时间窗: 10 days post-operatively

Patients recorded pain levels 3 times per day using Visual analog scales until study completion. Average daily pain was calculated for each patient. Higher values portend worse control.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Toufic R. Jildeh

Resident Investigator

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验